The town of Sommerville, Massachusetts. It's no secret that Bruce Rosenblum understands the medicine Relyvrio won't save his life. It's possible that it won't even make a difference. But he had been using a homemade version for a while until early this summer when he found out he couldn't obtain any more, and now he's keen to get back into it. Source The Food and Drug Administration (FDA) granted Relyvrio approval late Thursday for use in the treatment of amyotrophic lateral sclerosis (ALS). Rosenblum exclaimed, "This is fantastic news!" and promptly asked for a prescription. Preliminary results from the drug's clinical trials suggest it may be most effective in treating the earliest stages of the lethal condition. When faced with ALS, Rosenblum and others like them are left with few choices. Only five other medications have been approved to treat ALS (the most recent in 2017), and none of them have been found to slow or halt the progressive weakne...